Evaluation and Treatment of Vaginal Discharge with Pruritus
Perform immediate point-of-care testing with vaginal pH measurement, saline wet mount, and 10% KOH preparation to differentiate between the three most common causes: vulvovaginal candidiasis (VVC), bacterial vaginosis (BV), and trichomoniasis, then treat based on findings. 1
Diagnostic Algorithm
Step 1: Measure Vaginal pH
- Use narrow-range pH paper at the bedside; pH ≤4.5 indicates VVC, while pH >4.5 suggests BV or trichomoniasis. 1, 2
- This single test immediately narrows your differential and guides subsequent microscopy interpretation. 3
Step 2: Perform Saline Wet Mount
- Examine immediately for motile trichomonads (diagnostic of trichomoniasis), clue cells (BV), and inflammatory cells. 1, 2
- Motile trichomonads are visible in 50-75% of trichomoniasis cases; absence does not exclude the diagnosis. 4
- Clue cells (epithelial cells with adherent bacteria obscuring borders) present in >20% of cells strongly suggest BV. 4
Step 3: Perform 10% KOH Preparation
- Add KOH to a second sample to visualize yeast forms or pseudohyphae (diagnostic of VVC) and simultaneously perform the whiff test. 1, 2
- Yeast or pseudohyphae are visible in only 50-70% of true VVC cases, so negative microscopy does not rule out infection if symptoms are classic. 1, 4
- A positive whiff test (fishy odor when KOH is added) indicates BV or trichomoniasis. 3
Step 4: Assess Clinical Presentation
- VVC typically presents with thick white "cottage cheese" discharge, intense vulvar pruritus, vulvar erythema, and normal pH. 3, 1
- Trichomoniasis presents with yellow-green frothy discharge, malodor, vulvar irritation, and pH >4.5. 1, 5
- BV presents with thin homogeneous gray-white discharge, fishy odor, minimal pruritus, and pH >4.5. 4, 6
Treatment Based on Diagnosis
Vulvovaginal Candidiasis (Most Common Cause of Pruritus)
For uncomplicated VVC, prescribe either oral fluconazole 150 mg as a single dose OR a topical azole for 1-7 days. 3, 1
Topical Azole Options (equally effective):
- Clotrimazole 1% cream 5 g intravaginally daily for 7 days 3
- Miconazole 2% cream 5 g intravaginally daily for 7 days 3
- Terconazole 0.4% cream 5 g intravaginally daily for 7 days 3
- Single-dose options: Clotrimazole 500 mg vaginal tablet OR Tioconazole 6.5% ointment (for mild-to-moderate disease only) 1
For Complicated VVC (recurrent, severe, non-albicans species, diabetes, immunosuppression, pregnancy):
- Use extended topical azole therapy for 7-14 days OR fluconazole 150 mg on days 1 and 4. 3, 1
- For recurrent VVC (≥4 episodes/year), initiate maintenance therapy with fluconazole 150 mg weekly for 6 months after achieving initial cure. 3, 1
Trichomoniasis
Prescribe metronidazole 2 g orally as a single dose (90-95% cure rate) AND treat the sexual partner simultaneously. 3, 5
- Alternative regimen: Metronidazole 500 mg twice daily for 7 days 3
- Tinidazole 2 g single dose is equally effective with cure rates of 92-100%. 7
- Partner treatment is essential; treatment failure is usually due to untreated partners. 4
- Instruct patients to avoid sexual contact until both partners complete therapy and are asymptomatic. 3
Bacterial Vaginosis (If Present with Pruritus)
Prescribe metronidazole 500 mg orally twice daily for 7 days. 1, 6
- Alternative: Metronidazole 0.75% gel intravaginally daily for 5 days OR Clindamycin 2% cream intravaginally at bedtime for 7 days 6
- Partner treatment is NOT recommended for BV. 1
Concurrent Infections
If both VVC and BV are present (not uncommon), treat both simultaneously with metronidazole 500 mg twice daily for 7 days PLUS either fluconazole 150 mg single dose or 7-day topical azole. 1
- This is critical because metronidazole treatment precipitates VVC in 12.5-30% of patients. 1
Special Populations
Pregnancy
- Use ONLY 7-day topical azole therapy for VVC; oral fluconazole is contraindicated. 3, 1, 2
- Treat symptomatic trichomoniasis with metronidazole 2 g single dose to reduce preterm delivery risk. 3, 2
- Metronidazole is safe in pregnancy; multiple studies show no teratogenic effects. 3
HIV-Infected Patients
Critical Pitfalls to Avoid
- Never treat based solely on microscopic findings without symptoms; 10-20% of women harbor Candida as normal flora. 3, 1
- Do not recommend OTC self-treatment unless the patient has a prior confirmed VVC diagnosis and identical recurrent symptoms. 1
- Do not rely on symptoms alone; clinical presentation is not specific, and microscopic confirmation is essential. 1
- If symptoms persist after OTC treatment, obtain vaginal culture to identify non-albicans Candida species (especially C. glabrata), which account for 10-20% of refractory cases and require extended therapy. 1, 4
- Always test for coexisting STIs when clinically indicated; VVC can occur concomitantly with chlamydia or gonorrhea. 3, 1
When to Obtain Cultures
- Obtain vaginal culture if microscopy is negative but symptoms persist, if recurrent infections occur (≥4 episodes/year), or if treatment fails. 5, 8
- Culture identifies non-albicans species that may be azole-resistant. 4, 8